We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
(-5.5%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$162M |
| 2 |
Vertiv
VRT
|
+$52.4M |
| 3 |
Palo Alto Networks
PANW
|
+$34.3M |
| 4 |
Waters Corp
WAT
|
+$21.5M |
| 5 |
Pinnacle Financial Partners Inc
PNFP
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$607M |
| 2 |
Apple
AAPL
|
+$186M |
| 3 |
Microsoft
MSFT
|
+$139M |
| 4 |
Meta Platforms (Facebook)
META
|
+$89.6M |
| 5 |
NVIDIA
NVDA
|
+$74.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 10.32% |
| 4 | Industrials | 10.12% |
| 5 | Healthcare | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Huron Consulting
HURN
$1.99B
| $2.65M | ﹤0.01% |
20,776
-1,180
| -5% | -$177K |
|
1702
Tango Therapeutics
TNGX
$4.31B
| $2.65M | ﹤0.01% |
126,603
-2,504
| -2% | -$34.9K |
|
|
BELFB
1703
Bel Fuse Inc Class B
BELFB
$3.62B
| $2.65M | ﹤0.01% |
13,367
+44
| +0.3% | +$9.19K |
|
1704
Immunome
IMNM
$2.63B
| $2.64M | ﹤0.01% |
120,900
+7,335
| +6% | +$163K |
|
1705
National Beverage
FIZZ
$3.03B
| $2.64M | ﹤0.01% |
78,436
-293
| -0.4% | -$10.2K |
|
1706
Seaboard Corp
SEB
$4.37B
| $2.63M | ﹤0.01% |
466
+1
| +0.2% | +$5.01K |
|
1707
Edgewise Therapeutics
EWTX
$4.36B
| $2.63M | ﹤0.01% |
83,540
-1,535
| -2% | -$44.3K |
|
1708
United Parks & Resorts
PRKS
$2.16B
| $2.62M | ﹤0.01% |
80,175
+685
| +0.9% | +$24K |
|
1709
Cogent Communications
CCOI
$639M
| $2.6M | ﹤0.01% |
137,920
+459
| +0.3% | +$10.1K |
|
1710
Monarch Casino & Resort
MCRI
$2.21B
| $2.6M | ﹤0.01% |
27,148
+331
| +1% | +$31.5K |
|
1711
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
| $2.58M | ﹤0.01% |
29,371
| – | – |
|
1712
Banco Bilbao Vizcaya Argentaria
BBVA
$146B
| $2.58M | ﹤0.01% |
118,906
+6,187
| +5% | +$143K |
|
1713
Atkore
ATKR
$2.56B
| $2.57M | ﹤0.01% |
43,619
-887
| -2% | -$57.7K |
|
1714
Zillow
ZG
$7.68B
| $2.57M | ﹤0.01% |
62,023
-340
| -0.5% | -$18K |
|
1715
Intuitive Machines
LUNR
$2B
| $2.56M | ﹤0.01% |
138,038
+2,013
| +1% | +$37.1K |
|
|
PENG
1716
Penguin Solutions Inc
PENG
$2.47B
| $2.56M | ﹤0.01% |
145,350
+2,525
| +2% | +$48K |
|
|
SNCY
1717
DELISTED
Sun Country Airlines
SNCY
| $2.55M | ﹤0.01% |
154,281
+4,014
| +3% | +$71.7K |
|
|
DAWN
1718
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.54M | ﹤0.01% |
118,557
+6,878
| +6% | +$96.9K |
|
1719
Freedom Holding
FRHC
$9.86B
| $2.54M | ﹤0.01% |
17,533
+1,243
| +8% | +$159K |
|
1720
Braze
BRZE
$2.85B
| $2.54M | ﹤0.01% |
107,580
+5,075
| +5% | +$110K |
|
1721
Adaptive Biotechnologies
ADPT
$3.62B
| $2.54M | ﹤0.01% |
182,872
-1,764
| -1% | -$28.1K |
|
1722
BioCryst Pharmaceuticals
BCRX
$2.46B
| $2.53M | ﹤0.01% |
266,137
-425
| -0.2% | -$3.3K |
|
1723
1st Source
SRCE
$2.18B
| $2.53M | ﹤0.01% |
36,559
-1,937
| -5% | -$131K |
|
|
AXA
1724
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $2.51M | ﹤0.01% |
54,667
+1,049
| +2% | +$48.2K |
|
1725
Southside Bancshares
SBSI
$974M
| $2.5M | ﹤0.01% |
80,572
+1,147
| +1% | +$36.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
- RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
- RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
- RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
- RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
- RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.